ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,022Medicare Part D Prescriptions Filled, Including Refills

Rank: 70 out of 223

$409K Total Retail Price of All Prescriptions

Rank: 92 out of 223

518 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
15% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Utah
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 518 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

15% of this provider’s 518 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

3% of this provider’s 7,016 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $62 among peers.

Prescriptions per Patient

15 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Utah
LEVOTHYROXINE SODIUM 488 418 1 2
SIMVASTATIN 331 289 2 1
OMEPRAZOLE 280 247 3 3
HYDROCODONE-ACETAMINOPHEN 267 213 S3 4 5
SYNTHROID 266 250 5 35
LISINOPRIL 266 253 5 4
ZOLPIDEM TARTRATE 252 206 7 8
AMLODIPINE BESYLATE 200 176 8 6
SERTRALINE HCL 177 172 9 21
METFORMIN HCL 175 163 10 7
ATORVASTATIN CALCIUM 175 160 10 17
TRAMADOL HCL 131 120 12 18
CITALOPRAM HBR 131 108 12 16
GABAPENTIN 123 95 14 10
METOPROLOL TARTRATE 117 114 15 25
FUROSEMIDE 107 102 16 9
POTASSIUM CHLORIDE 104 99 17 12
ALENDRONATE SODIUM 95 82 18 19
TRIAMTERENE-HCTZ 94 90 19 39
LISINOPRIL-HYDROCHLOROTHIAZIDE 93 87 20 29
GLIMEPIRIDE 92 87 21 30
LOSARTAN POTASSIUM 86 86 22 14
TRAZODONE HCL 82 64 23 22
LOSARTAN-HYDROCHLOROTHIAZIDE 79 72 24 31
CYCLOBENZAPRINE HCL 78 69 R 25 79
WARFARIN SODIUM 77 71 26 11
AZITHROMYCIN 71 59 27 44
ATENOLOL 70 62 28 32
MORPHINE SULFATE ER 66 21 S2 29 90
PRAVASTATIN SODIUM 66 65 29 15
LANTUS SOLOSTAR 63 60 31 74
METOPROLOL SUCCINATE 60 51 32 20
HYDROCHLOROTHIAZIDE 59 56 33 13
PANTOPRAZOLE SODIUM 51 44 34 45
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 9, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.